Senseonics (NYSE:SENS) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Senseonics (NYSE:SENS) in a report published on Thursday morning. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Friday, November 15th.

Senseonics Price Performance

Shares of NYSE:SENS opened at $0.59 on Thursday. The firm has a market capitalization of $348.86 million, a PE ratio of -4.51 and a beta of 0.77. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. Senseonics has a 1-year low of $0.25 and a 1-year high of $0.75. The business’s 50 day moving average is $0.35 and its 200-day moving average is $0.38.

Insiders Place Their Bets

In other news, CEO Timothy T. Goodnow bought 315,000 shares of Senseonics stock in a transaction dated Tuesday, December 10th. The shares were bought at an average price of $0.31 per share, for a total transaction of $97,650.00. Following the purchase, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Frederick T. Sullivan bought 124,933 shares of the stock in a transaction dated Thursday, December 12th. The stock was purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the acquisition, the chief financial officer now owns 2,478,844 shares in the company, valued at $941,960.72. The trade was a 5.31 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company’s stock.

Institutional Trading of Senseonics

Hedge funds have recently modified their holdings of the company. Geode Capital Management LLC grew its holdings in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after purchasing an additional 179,103 shares during the last quarter. FMR LLC lifted its position in Senseonics by 48,267.2% during the 3rd quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after buying an additional 167,970 shares in the last quarter. GSA Capital Partners LLP bought a new stake in Senseonics during the 3rd quarter worth about $117,000. Symmetry Partners LLC acquired a new stake in Senseonics in the 3rd quarter valued at about $164,000. Finally, Cubist Systematic Strategies LLC raised its stake in shares of Senseonics by 25.9% in the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after acquiring an additional 85,501 shares during the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.